Page last updated: 2024-08-23

phytanic acid and Chondrodysplasia Punctata, Rhizomelic

phytanic acid has been researched along with Chondrodysplasia Punctata, Rhizomelic in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (44.44)18.2507
2000's2 (22.22)29.6817
2010's2 (22.22)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Braverman, NE; Gavrilov, DK; Loken, PR; Matern, D; Oglesbee, D; Raymond, KM; Stoway, SD; Tortorelli, S; Wegwerth, PJ; White, AL1
Braverman, NE; Çim, A; Coşkun, S; Görükmez, O; Pietro, ED; Plourde, F; Uluca, Ü; Yüksel, H1
Braverman, N; Chaudhury, R; Chen, L; Moser, A; Nimmo, G; Scheper, S; Steinberg, S; Tran, T; Zhang, R1
Baes, M; Brites, P; Carmeliet, P; Dewerchin, M; Duran, M; Everts, V; Evrard, P; Gressens, P; Mooyer, PA; Motley, AM; Ploegaert, I; Schoonjans, L; Wanders, RJ; Waterham, HR1
van den Brink, DM; Wanders, RJ1
Khan, M; Pahan, K; Singh, I1
Barth, PG; Schutgens, RB; Staalman, CR; Wanders, RJ1
Lima, MR; Mota, CR; Nogueira, A; Vilarinho, A1
Kenjarski, TP; Moser, AB; Moser, HW; Powers, JM1

Reviews

2 review(s) available for phytanic acid and Chondrodysplasia Punctata, Rhizomelic

ArticleYear
A new test method for biochemical analysis of plasmalogens in dried blood spots and erythrocytes from patients with peroxisomal disorders.
    Journal of inherited metabolic disease, 2023, Volume: 46, Issue:6

    Topics: Chondrodysplasia Punctata, Rhizomelic; Humans; Infant, Newborn; Peroxisomal Disorders; Phytanic Acid; Plasmalogens; Zellweger Syndrome

2023
Phytanic acid: production from phytol, its breakdown and role in human disease.
    Cellular and molecular life sciences : CMLS, 2006, Volume: 63, Issue:15

    Topics: Aldehyde Oxidoreductases; Chondrodysplasia Punctata, Rhizomelic; Humans; Oxidation-Reduction; Peroxisomal Disorders; Peroxisomes; Phytanic Acid; Phytol; Protein Transport; Refsum Disease

2006

Other Studies

7 other study(ies) available for phytanic acid and Chondrodysplasia Punctata, Rhizomelic

ArticleYear
Rhizomelic Chondrodysplasia Punctata Type 1 Caused by a Novel Mutation in the PEX7 Gene.
    Journal of clinical research in pediatric endocrinology, 2015, Volume: 7, Issue:1

    Topics: Child; Chondrodysplasia Punctata, Rhizomelic; Female; Gas Chromatography-Mass Spectrometry; Heterozygote; Homozygote; Humans; Male; Mutation; Pedigree; Peroxisomal Targeting Signal 2 Receptor; Phytanic Acid; Polymerase Chain Reaction; Receptors, Cytoplasmic and Nuclear

2015
A Pex7 hypomorphic mouse model for plasmalogen deficiency affecting the lens and skeleton.
    Molecular genetics and metabolism, 2010, Volume: 99, Issue:4

    Topics: Animals; Bone and Bones; Cells, Cultured; Chondrodysplasia Punctata, Rhizomelic; Dietary Supplements; Disease Models, Animal; Glyceryl Ethers; Lens, Crystalline; Mice; Mice, Inbred C57BL; Mice, Transgenic; Peroxisomal Targeting Signal 2 Receptor; Peroxisomes; Phenotype; Phytanic Acid; Plasmalogens; Receptors, Cytoplasmic and Nuclear; Tissue Distribution

2010
Impaired neuronal migration and endochondral ossification in Pex7 knockout mice: a model for rhizomelic chondrodysplasia punctata.
    Human molecular genetics, 2003, Sep-15, Volume: 12, Issue:18

    Topics: Acetyl-CoA C-Acetyltransferase; Animals; Animals, Newborn; Brain; Cell Movement; Cells, Cultured; Chondrodysplasia Punctata, Rhizomelic; Diet; Fibroblasts; Gene Targeting; Liver; Mice; Mice, Knockout; Mutation; Neurons; Osteoblasts; Osteoclasts; Osteogenesis; Oxidation-Reduction; Peroxisomal Targeting Signal 2 Receptor; Peroxisomes; Phytanic Acid; Phytol; Plasmalogens; Receptors, Cytoplasmic and Nuclear; Time Factors

2003
Phytanic acid oxidation: normal activation and transport yet defective alpha-hydroxylation of phytanic acid in peroxisomes from Refsum disease and rhizomelic chondrodysplasia punctata.
    Journal of lipid research, 1996, Volume: 37, Issue:5

    Topics: Biological Transport; Cells, Cultured; Chondrodysplasia Punctata, Rhizomelic; Coenzyme A; Fibroblasts; Humans; Hydroxylation; Microbodies; Oxidation-Reduction; Phytanic Acid; Reference Values; Refsum Disease

1996
Variant rhizomelic chondrodysplasia punctata (RCDP) with normal plasma phytanic acid: clinico-biochemical delineation of a subtype and complementation studies.
    American journal of medical genetics, 1996, Mar-15, Volume: 62, Issue:2

    Topics: Cells, Cultured; Child; Chondrodysplasia Punctata, Rhizomelic; Female; Fibroblasts; Humans; Intellectual Disability; Phytanic Acid

1996
Rhizomelic chondrodysplasia punctata-like phenotype in a newborn male with normal peroxisomal function.
    Journal of pediatric orthopedics. Part B, 1997, Volume: 6, Issue:1

    Topics: Acyltransferases; Chondrodysplasia Punctata, Rhizomelic; Dihydroxyacetone Phosphate; Dwarfism; Fatal Outcome; Fatty Acids; Humans; Infant, Newborn; Male; Phenotype; Phytanic Acid; Plasmalogens; Radiography; Respiratory Insufficiency

1997
Cerebellar atrophy in chronic rhizomelic chondrodysplasia punctata: a potential role for phytanic acid and calcium in the death of its Purkinje cells.
    Acta neuropathologica, 1999, Volume: 98, Issue:2

    Topics: Atrophy; Calcium; Cell Death; Cerebellum; Child; Chondrodysplasia Punctata, Rhizomelic; Chronic Disease; Female; Humans; Infant; Male; Phytanic Acid; Purkinje Cells

1999